Strategic Advocates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$370 272
2026
Q1
$370 Hold
3
﹤0.01% 253
2025
Q4
$398 Sell
3
-458
-99% -$53.8K ﹤0.01% 559
2025
Q3
$43.8K Buy
+461
New +$45.7K 0.01% 210
2024
Q2
Sell
-2,727
Closed -$364K 129
2024
Q1
$364K Sell
2,727
-10,505
-79% -$1.41M 0.14% 81
2023
Q4
$1.79M Buy
13,232
+1,044
+9% +$120K 0.76% 27
2023
Q3
$1.63M Buy
+12,188
New +$2M 0.77% 25

Other funds holding ILMN

Strategic Advocates's ILMN Position: Q2 2026 in Review

Strategic Advocates sold out of Illumina (ILMN) in Q2 2026, closing a stake of 3 shares — an estimated $370 sold.

Strategic Advocates first reported a position in ILMN in Q3 2023 and held it in 6 quarters. The position peaked at $1.79M in Q4 2023. 938 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Strategic Advocates reported no remaining Illumina position as of Q2 2026 after selling out during the quarter.
  • Strategic Advocates sold 3 Illumina shares in Q2 2026, an estimated $370.
  • Strategic Advocates first reported a position in Illumina in Q3 2023 and held it in 6 quarters.
  • Strategic Advocates's Illumina position peaked at $1.79M in Q4 2023.
  • 938 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.